This is the authors' abstract. We don't add key points for this paper.
Progesterone levels rapidly increase following the administration of human chorionic gonadotrophin (hCG), which is given to induce final oocyte maturation during the in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles. It is unclear whether elevated progesterone levels on the day of hCG administration influence the ongoing pregnancy rates achieved with IVF. Although several studies, including a recent meta-analysis, found no association between progesterone levels on the day of hCG administration and ongoing pregnancy rates, others have shown an inverse relationship between serum progesterone and pregnancy rates. The value of most studies failing to demonstrate an association between serum progesterone levels and pregnancy rates (including those analyzed in the meta-analysis) are limited because of the use of heterogeneous assays and different, arbitrarily defined, serum progesterone threshold values. This noninterventional, retrospective, observational, single-center cohort study investigated the relationship between serum progesterone levels on the day of hCG administration and the probability of ongoing pregnancy among an unselected population of women undergoing IVF/ICSI cycles. A total of 4032 patients treated at a fertility center in Spain received either a gonadotropin releasing hormone (GnRH) agonist long protocol (n = 1177) or a GnRH antagonist daily protocol (n = 2855) for pituitary downregulation. Multivariate logistic regression analysis was performed to adjust for confounding variables associated with serum progesterone levels. There was an inverse relationship between ongoing pregnancy rates and serum progesterone levels on the day of hCG (P < 0.001 for overall trend), irrespective of whether GnRH agonists or antagonists were used for pituitary downregulation. Significantly higher ongoing pregnancy rates were achieved in patients with serum progesterone levels ≤1.5 ng/mL as compared with patients having progesterone levels >1.5 ng/mL (31.0% vs. 19.1%; P = 0.00006); the odds ratio was 0.53, with a 95% confidence interval of 0.38 to 0.72. Multivariate analysis demonstrated that increases in daily dosage of follicle-stimulating hormone, number of oocytes collected, and estradiol (E2) values on the day of hCG administration were associated with increased progesterone levels (P < 0.0001 for all comparisons). Significantly higher serum progesterone levels were found among women treated with GnRH agonists as compared with those receiving GnRH antagonists (0.84 ± 0.67 vs. 0.75 ± 0.66 ng/mL; P = 0.0003). These findings show that high serum progesterone levels on the day of hCG administration are associated with reduced ongoing pregnancy rates after IVF/ICSI cycles irrespective of the GnRH analog used for pituitary downregulation. The data suggest that a concentration of 1.5 ng/mL is the critical threshold level above which the progesterone level has a negative effect on pregnancy rate.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bosch et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: